1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        MEA Pharma ADMET Testing Market – By Testing Type

1.3.2        MEA Pharma ADMET Testing Market – By Technology

1.3.3        MEA Pharma ADMET Testing Market – By Application

1.3.4        MEA Pharma ADMET Testing Market – By Country

2.           MEA Pharma ADMET Testing Market– Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           MEA Pharma ADMET Testing Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        MEA – PEST Analysis

4.3         Expert Opinion

5.           Pharma ADMET Testing Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        High Rate of Late-Stage Drug Failure

5.1.2        Increasing Number of Product Approvals and Launches

5.2         Market Restraints

5.2.1        High Cost of ADME Testing Studies

5.3         Market Opportunities

5.3.1        Automation and Advancements in ADME Testing

5.4         Future Trends

5.4.1        The Advent of High-Throughput Screening

5.5         Impact Analysis

6.           Pharma ADMET Testing Market– MEA Analysis

6.1         MEA Pharma ADMET Testing Market Revenue Forecast and Analysis

7.           MEA Pharma ADMET Testing Market– By Testing Type

7.1         Overview

7.2         MEA Pharma ADMET Testing Market, By Testing Type 2022 & 2028 (%)

7.3         In Vivo ADMET Testing

7.3.1        Overview

7.3.2        In Vivo ADMET Testing - Revenue and Forecast to 2028 (US$ Million)

7.4         In Vitro ADMET Testing

7.4.1        Overview

7.4.2        In Vitro ADMET Testing - Revenue and Forecast to 2028 (US$ Million)

7.5         In Silico ADMET Testing

7.5.1        Overview

7.5.2        In Silico ADMET Testing - Revenue and Forecast to 2028 (US$ Million)

8.           MEA Pharma ADMET Testing Market– By Technology

8.1         Overview

8.2         MEA Pharma ADMET Testing Market, By Technology 2022 & 2028 (%)

8.3         Cell Culture

8.3.1        Overview

8.3.2        Cell Culture - Market Revenue and Forecast to 2028 (US$ Million)

8.4         High Throughput

8.4.1        Overview

8.4.2        High Throughput - Market Revenue and Forecast to 2028 (US$ Million)

8.5         Molecular Imaging

8.5.1        Overview

8.5.2        Molecular Imaging - Market Revenue and Forecast to 2028 (US$ Million)

8.6         OMICS Technology

8.6.1        Overview

8.6.2        OMICS Technology - Market Revenue and Forecast to 2028 (US$ Million)

9.           MEA Pharma ADMET Testing Market– By Application

9.1         Overview

9.2         MEA Pharma ADMET Testing Market, By Application 2022 & 2028 (%)

9.3         Systemic Toxicity

9.3.1        Overview

9.3.2        Systemic Toxicity - Market Revenue and Forecasts to 2028 (US$ Million)

9.4         Renal Toxicity

9.4.1        Overview

9.4.2        Renal Toxicity - Market Revenue and Forecasts to 2028 (US$ Million)

9.5         Hepatotoxicity

9.5.1        Overview

9.5.2        Hepatotoxicity - Market Revenue And Forecasts to 2028 (US$ Million)

9.6         Neurotoxicity

9.6.1        Overview

9.6.2        Neurotoxicity - Market Revenue And Forecasts to 2028 (US$ Million)

9.7         Others

9.7.1        Overview

9.7.2        Others - Revenue And Forecasts to 2028 (US$ Million)

10.        MEA Pharma ADMET Testing Market– Country Analysis

10.1      MEA: Pharma ADMET Testing Market

10.1.1     Overview

10.1.2     MEA Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)

10.1.2.1       UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.1.1       Overview

10.1.2.1.2       UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.1.3       UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)

10.1.2.1.4       UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.1.2.1.5       UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.2.2       Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.2.1       Overview

10.1.2.2.2       Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.2.3       Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)

10.1.2.2.4       Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.1.2.2.5       Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.2.3       South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.3.1       Overview

10.1.2.3.2       South Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.3.3       South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)

10.1.2.3.4       South Africa: Metabolomics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

10.1.2.3.5       South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Application (US$ Million)

10.1.2.4       Rest of MEA: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.4.1       Overview

10.1.2.4.2       Rest of MEA: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

10.1.2.4.3       Rest of MEA: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)

10.1.2.4.4       Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

10.1.2.4.5       Rest of MEA: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Application (US$ Million)

11.        MEA Pharma ADMET Testing Market–Industry Landscape

11.1      Overview

11.2      Organic Developments

11.2.1     Overview

11.3      Inorganic Developments

11.3.1     Overview

12.        Company Profiles

12.1      Charles River Laboratories

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      WuXi AppTec

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Promega Corporation

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Sigma-Aldrich (MERCK KGaA)

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Agilent Technologies, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Biovia (Dassault Systèmes)

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      Bio-Rad Laboratories, Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      IQVIA Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

LIST OF TABLES

Table 1.             MEA Pharma ADMET Testing Market –Revenue and Forecast to 2028 (US$ Million)

Table 2.             UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)

Table 3.             UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 4.             UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 5.             Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)

Table 6.             Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 7.             Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 8.             South Africa Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)

Table 9.             South Africa: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 10.          South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 11.          Rest of MEA: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Testing Type (US$ Million)

Table 12.          Rest of MEA: Metabolomics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

Table 13.          Rest of MEA: Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Application (US$ Million)

Table 14.          Organic Developments Done by Companies

Table 15.          Inorganic Developments Done by Companies

Table 16.          Glossary of Terms

LIST OF FIGURES

Figure 1.           MEA Pharma ADMET Testing Market Segmentation

Figure 2.           MEA Pharma ADMET Testing Market, By Country

Figure 3.           MEA Pharma ADMET Testing Market Overview

Figure 4.           In vivo ADMET Testing Segment Held Largest Share of Testing Type Segment in MEA Pharma ADMET Testing Market

Figure 5.           South Africa is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           MEA: PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           MEA Pharma ADMET Testing Market Impact Analysis of Driver and Restraints

Figure 9.           MEA Pharma ADME Testing Market– Revenue Forecast and Analysis – 2022 - 2028

Figure 10.        MEA Pharma ADMET Testing Market, by Testing Type 2022 & 2028 (%)

Figure 11.        In Vivo ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        In Vitro ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        In Silico ADMET Testing - Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        MEA Pharma ADMET Testing Market, by Technology 2022 & 2028 (%)

Figure 15.        Cell Culture - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        High Throughput - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17.        Molecular Imaging - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        OMICS Technology - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        MEA Pharma ADMET Testing Market, by Application 2022 & 2028 (%)

Figure 20.        Systemic Toxicity - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Renal Toxicity - Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Hepatotoxicity - Market Revenue And Forecasts to 2028 (US$ Million)

Figure 23.        Neurotoxicity - Market Revenue And Forecasts to 2028 (US$ Million)

Figure 24.        Others - Revenue And Forecasts to 2028 (US$ Million)

Figure 25.        MEA Pharma ADMET Testing Market Revenue Overview, by Country, 2022 (US$ Million)

Figure 26.        MEA Pharma ADMET Testing Market Revenue and Forecasts to 2028, By Country (%)

Figure 27.        UAE: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 28.        Saudi Arabia: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 29.        South Africa: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)

Figure 30.        Rest of MEA: Pharma ADMET Testing Market Revenue and Forecasts to 2028 (US$ Million)